Matsubara et al. [19] showed that SMARCA4 deletion is more involved in the progression of EGFR wild-type lung cancer but not EGFR-mutant tumors, and it was hypothesized that the coexistence of EGFR mutation and SMARCA4 deletion is not suitable for the survival of tumor cells. Here, SMARCA4 is linked to lung cancer.